Evidence map›Paper›PMID 24039981›Full record

Trial reportPloS one2013

Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?

Agnes Ssali, Stella Namukwaya, Leonard Bufumbo, Janet Seeley, David G Lalloo, Anatoli Kamali, Rosalind Parkes-Ratanshi

Open access · goldAbstract readClinical Trial, Phase III
In one paragraph

Trial report in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Unintended drug exposure during pregnancy in clinical trials - a survey in early drug development.International journal of clinical pharmacology and therapeutics · 2021
    Trial
  2. Trial
  3. Review
  4. Article
  5. Women's Views About a Paternal Consent Requirement for Biomedical Research in Pregnancy.Journal of empirical research on human research ethics : JERHRE · 2018
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Agnes SsaliMRC/UVRI Uganda Research Unit on AIDS, Uganda Virus Research Institute (UVRI), Entebbe, Uganda.
Stella Namukwaya
Leonard Bufumbo
Janet Seeley
David G Lalloo
Anatoli Kamali
Rosalind Parkes-Ratanshi
Uganda Virus Research Institute · UGLiverpool School of Tropical Medicine · GBInternational Hospital Kampala · UGUniversity of East Anglia · GB

Funding

Medical Research Council G0100137Medical Research Council MC_U122861322Medical Research Council MC_UU_12023/1
6 · The paper itself

Abstract

objectiveHigher than expected pregnancy rates have been observed in HIV related clinical trials in Sub-Saharan Africa. We designed a qualitative study to explore the factors contributing to high pregnancy rates among participants in two HIV clinical trials in Sub-Saharan Africa.

methodsFemale and male participants enrolled in one of two clinical HIV trials in south-west Uganda were approached. The trials were a phase III microbicide efficacy trial among HIV negative women using vaginal gel (MDP); and a trial of primary prevention prophylaxis for invasive cryptococcal disease using fluconazole among HIV infected men and women in Uganda (CRYPTOPRO). 14 focus group discussions and 8 in-depth interviews were conducted with HIV positive and negative women and their male partners over a six month period. Areas explored were their experiences about why and when one should get pregnant, factors affecting use of contraceptives, HIV status disclosure and trial product use.

resultsAll respondents acknowledged being advised of the importance of avoiding pregnancy during the trial. Factors reported to contribute to pregnancy included; trust that the investigational product (oral capsules/vaginal gel) would not harm the baby, need for children, side effects that led to inconsistent contraceptive use, low acceptance of condom use among male partners. Attitudes towards getting pregnant are fluid within couples over time and the trials often last for more than a year. Researchers need to account for high pregnancy rates in their sample size calculations, and consider lesser used female initiated contraceptive options e.g. diaphragm or female condoms. In long clinical trials where there is a high fetal or maternal risk due to investigational product, researchers and ethics committees should consider a review of participants contraceptive needs/pregnancy desire review after a fixed period, as need for children, partners and health status of participants may alter over time.

Indexed as

Pregnancy RateAdultAfrica South of the SaharaAntifungal AgentsCondomsContraceptionContraceptive Devices, FemaleCryptococcosisFemaleFluconazoleHIV InfectionsHumansMalePregnancyPregnancy Complications, InfectiousSexual BehaviorAntifungal AgentsFluconazoleSpermatocidal AgentsVaginal Creams, Foams, and Jellies

Identifiers

PMID24039981
PMCPMC3769278
OpenAlexW2040552615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.